Study Objectives We investigated the association of HIV infection and highly active antiretroviral therapy (HAART) with sleep disordered breathing (SDB), fatigue, and sleepiness. Methods HIV-uninfected men (HIV？; n = 60), HIV-infected men using HAART (HIV+/HAART+; n = 58), and HIV-infected men not using HAART (HIV+/HAART？; n = 41) recruited from two sites of the Multicenter AIDS cohort study (MACS) underwent a nocturnal sleep study, anthropometric assessment, and questionnaires for fatigue and the Epworth Sleepiness Scale. The prevalence of SDB in HIV- men was compared to that in men matched from the Sleep Heart Health Study (SHHS). Results The prevalence of SDB was unexpectedly high in all groups: 86.7% for HIV？, 70.7% for HIV+/HAART+, and 73.2% for HIV+/HAART？, despite lower body-mass indices (BMI) in HIV+ groups. The higher prevalence in the HIV？ men was significant in univariate analyses but not after adjustment for BMI and other variables. SDB was significantly more common in HIV？ men in this study than those in SHHS, and was common in participants with BMIs <25 kg/m2. HIV+ men reported fatigue more frequently than HIV？ men (25.5% vs. 6.7%; p = 0.003), but self-reported sleepiness did not differ among the three groups. Sleepiness, but not fatigue, was significantly associated with SDB. Conclusions SDB was highly prevalent in HIV？ and HIV+ men, despite a normal or slightly elevated BMI. The high rate of SDB in men who have sex with men deserves further investigation. Sleepiness, but not fatigue, was related to the presence of SDB. Clinicians caring for HIV-infected patients should distinguish between fatigue and sleepiness when considering those at risk for SDB, especially in non-obese men.
Adams N, Strauss M, Schluchter M, Redline S (2001) Relation of measures of sleep-disordered breathing to neuropsychological functioning. Am J Respir Crit Care Med 163: 1626–1631. doi: 10.1164/ajrccm.163.7.2004014
Ferrando S, Evans S, Goggin K, Sewell M, Fishman B, et al. (1998) Fatigue in HIV illness: relationship to depression, physical limitations, and disability. PsychosomMed 60: 759–764. doi: 10.1097/00006842-199811000-00019
Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J (2001) A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161: 411–420. doi: 10.1001/archinte.161.3.411
Dorey-Stein Z, Amorosa VK, Kostman JR, Lo RV III, Shannon RP (2008) Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy. J CardiometabSyndr 3: 111–114. doi: 10.1111/j.1559-4572.2008.07552.x
Carr A, Samaras K, Burton S, Law M, Freund J, et al. (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51–F58. doi: 10.1097/00002030-199807000-00003
Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351: 1881–1883. doi: 10.1016/s0140-6736(98)03391-1
Wand H, Calmy A, Carey DL, Samaras K, Carr A, et al. (2007) Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 21: 2445–2453. doi: 10.1097/qad.0b013e3282efad32
Dusserre E, Moulin P, Vidal H (2000) Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. BiochimBiophysActa 1500: 88–96. doi: 10.1016/s0925-4439(99)00091-5
Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, et al. (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. AmJEpidemiol 126: 310–318. doi: 10.1093/aje/126.2.310
Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK (2002) Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 137: 381–433. doi: 10.7326/0003-4819-137-5_part_2-200209031-00001
Palella FJ Jr, Cole SR, Chmiel JS, Riddler SA, Visscher B, et al. (2004) Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study. Clin InfectDis 38: 903–907. doi: 10.1086/381684
Iber C, Ancoli-Israel S, Chesson AL, Quan SF (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine.
American Academy of Sleep M (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22: 667–689.
Johns MW (2000) Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth Sleepiness Scale: Failure of the MSLT as a gold standard. J Sleep Res 9: 5–11. doi: 10.1046/j.1365-2869.2000.00177.x
Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV (2004) Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 27: 1255–1273.
Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, et al. (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. AmJRespirCrit Care Med 165: 677–682. doi: 10.1164/ajrccm.165.5.2104087
Martinez E, Visnegarwala F, Grund B, Thomas A, Gibert C, et al. (2010) The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters. AIDS 24: 353–363. doi: 10.1097/qad.0b013e3283333666
Darko DF, Miller JC, Gallen C, White J, Koziol J, et al. (1995) Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. ProcNatlAcadSciUSA 92: 12080–12084. doi: 10.1073/pnas.92.26.12080
Opp MR, Rady PL, Hughes TK Jr, Cadet P, Tyring SK, et al. (1996) Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats [published errata appear in Am J Physiol 1996 Aug; 271(2 Pt 2):section R following table of contents and 1996 Dec; 271(6 Pt 3):section R following table of contents]. Am J Physiol 270: R963–R970.
Brown TT, Patil SP, Jacobson LP, Margolick JB, Laffan AM, et al. (2010) Anthropometry in the prediction of sleep disordered breathing in HIV-positive and HIV-negative men. AntivirTher 15: 651–659. doi: 10.3851/imp1572
Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, et al. (2004) Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. JClinEndocrinolMetab 89: 4409–4413. doi: 10.1210/jc.2003-031929
Haponik EF, Smith PL, Bohlman ME, Allen RP, Goldman SM, et al. (1983) Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. AmRevRespirDis 127: 221–226. doi: 10.1097/00004728-198312000-00060
Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman EA, et al. (1995) Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J RespirCrit Care Med 152: 1673–1689. doi: 10.1164/ajrccm.152.5.7582313
Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, et al. (1998) Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. JClinEndocrinolMetab 83: 1573–1579. doi: 10.1210/jcem.83.5.4795
Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, et al. (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82: 1313–1316. doi: 10.1210/jcem.82.5.3950
Vgontzas AN, Bixler EO, Papanicolaou D, Kales A, Chrousos GP (1999) Plasma concentrations of tumor necrosis factor alpha (TNF), interleukin-6 (IL-6) and leptin are elevated in sleep apnea independent of obesity. Sleep 22: S331.
Hossain JL, Reinish LW, Kayumov L, Bhuiya P, Shapiro CM (2003) Underlying sleep pathology may cause chronic high fatigue in shift-workers. J Sleep Res 12: 223–230. doi: 10.1046/j.1365-2869.2003.00354.x
Terao A, Matsumura H, Yoneda H, Saito M (1998) Enhancement of slow-wave sleep by tumor necrosis factor-alpha is mediated by cyclooxygenase-2 in rats. Neuroreport 9: 3791–3796. doi: 10.1097/00001756-199812010-00005